publication venue for
- Evaluating sleep in covert encephalopathy with wearable technology: results from the WATCHES study.. 7. 2023
- Prospective study of a case-finding algorithm to detect NAFLD with advanced fibrosis in primary care patients.. 7. 2023
- Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.. 7. 2023
- Clinical and demographic predictors of survival for fibrolamellar carcinoma patients-A patient community, registry-based study.. 6. 2022
- Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.. 6. 2022
- Identification of Quantifiable Predictors of Relapse in Patients with Alcohol-Associated Liver Disease.. 5. 2021
- Hepatitis C Virus Infection in Populations With Liver-Related Diseases in the Middle East and North Africa.. 4. 2020
- Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET Analysis.. 3. 2019
- Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro.. 3. 2019
- Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohort.. 2. 2018
- Nicotinamide N-methyltransferase expression decreases in iron overload, exacerbating toxicity in mouse hepatocytes.. 1. 2017
- The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice.. 1. 2017
- Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests. 2019